BOCA RATON, Fla. (July 26, 2017) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that the SRT-100™ has been cleared by
Treatment with Sensus Healthcare’s SRT-100™ following surgical removal of this man’s keloids reduced the chance of recurrence to just 4%. Click here to view the full article on FOX6NOW.com.
BOCA RATON, Fla. – July 19, 2017 – Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions, such as keloids with Superficial Radiation Therapy (SRT), announced that
Michael E. Jones, MD,* Jennifer McLane, FNP,* Rachael Adenegan, FNP-C,* JoAnne Lee, PA-BC,* and Christine A. Ganzer, PMHNP, PhD† BACKGROUND/OBJECTIVE Management of keloids of the pinna, in particular, those located in the helix and antihelix and lobule that occur as
Skin cancer generally appears within the first two to three millimeters of the surface of the skin. “The traditional way to treat skin cancer is surgery,” said Dr. Jeffrey Brackeen, with the Skin Cancer Institute of Lubbock. The SRT-100, he
The National Cancer Institute estimates 40-50% of Americans age 65 and over will have skin cancer at least once. Joe Sardano with Sensus Healthcare stopped by to tell us about its SRT technology the company says provides patients a safe,
While Mohs surgery has proven to be an extremely effective method of treatment for non-melanoma skin cancers like squamous cell carcinoma and basal cell carcinoma, there are many significant downsides to this procedure from a patient’s perspective. Depending on the
The symptoms of squamous cell carcinoma often appear as scaly, irritated skin, or elevated growths similar to warts. Only a trained physician or specialist can decide for sure if it is squamous cell carcinoma. If you believe you may have
With Sensus’ superficial radiation therapy (SRT), we may be entering uncharted waters where keloid recurrence after surgery and SRT leads to no, or a very low, incidence of keloid recurrence. With this, we will change the paradigm in the treatment
FIND AN SRT PROVIDER >
CONNECT WITH AN SRT REP >
No Cutting
No Pain
No Downtime
No Scarring